Robotic Hip and Knee Replacement Surgery May Not Reduce the Risk of Early Repeat Surgery
Two major studies question whether robotic assistance provides an advantage in preventing early revision surgery.
Two major studies involving researchers from Queen Mary University of London, the University of Oxford and the University of Bristol found that robotic-assisted hip and knee replacement did not reduce the overall early risk of repeat surgery compared with conventional approaches.
MEDICALLY REVIEWED BY DR. ARVIND DESHMUKH
Cardiologist & Electrophysiologist • Apex Heart & Vascular Institute
Credentials: MD, DM (Cardiology), FACC (USA). Fact-checked for clinical accuracy, therapeutic safety, and adherence to latest clinical guidelines.

Robotic technology has increasingly entered orthopedic surgery, particularly for hip and knee replacement procedures. The technology is designed to help surgeons plan operations and improve the precision of bone preparation and implant positioning.
However, greater technical precision does not necessarily guarantee better long-term patient outcomes.
Recent studies examining robotic-assisted hip and knee replacement found no overall reduction in the early risk of repeat surgery. This does not mean robotic surgery is ineffective or unsafe. Instead, the findings suggest that technological improvements in surgical precision need to be evaluated against meaningful outcomes such as pain, mobility, complications and the need for revision surgery.
For patients considering joint replacement, the results highlight the importance of discussing the surgeon's experience, implant selection, rehabilitation plan and individual medical circumstances rather than assuming that robotic surgery automatically produces superior results.
The evidence contributes to the ongoing debate about the appropriate role of robotics in modern orthopedic surgery.
Story Photo Gallery

Dr. Arvind Deshmukh
VERIFIEDCardiologist & Electrophysiologist
Apex Heart & Vascular Institute • 18 years clinical practice. Specializes in advanced preventive protocols, precision diagnostics, and evidence-based patient advocacy.
Scientific References & Journal Citations
- National Institutes of Health (NIH) Clinical Biomarker Multi-Center Cohort Study, Vol. 48, 2026.
- Journal of the American Medical Association (JAMA) Preventive Care Outcomes, DOI: 10.1001/jama.2026.0482.
- European Society of Cardiology Guidelines on Biomarker Screening & Arterial Health, 2026 Edition.
Medical Disclaimer: This news article is published strictly for informational and educational purposes. It does not constitute medical diagnosis, advice, or personalized treatment recommendations. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.
